% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Goerttler:1032442,
author = {Goerttler, Tsepo and Dorner, Martin B. and van der Linden,
Christina and Kienitz, Ricardo and Petrik, Stephan and
Blechinger, Stephan and Spickschen, Jonah and Betz, Iris R.
and Hinrichs, Carl and Steindl, David and Weber, Frederike
and Musacchio, Thomas and Wunderlich, Gilbert and Rueger,
Maria Adele and Barbe, Michael T. and Dafsari, Haidar and
Demir, Seda and Lapa, Sriramya and Zeiner, Pia S. and
Strzelczyk, Adam and Tinnemann, Peter and Kleine, Christian
and Totzeck, Andreas and Klebe, Stephan and Mikolajewska,
Agata and Dorner, Brigitte G. and Fertl, Elisabeth and
Grefkes-Hermann, Christian and Fink, Gereon and
Kleinschnitz, Christoph and Hagenacker, Tim},
title = {{I}atrogenic botulism after intragastric botulinum
neurotoxin injections – a major outbreak},
journal = {Neurological research and practice},
volume = {6},
number = {1},
issn = {2524-3489},
address = {[London]},
publisher = {BioMed Central},
reportid = {FZJ-2024-06248},
pages = {52},
year = {2024},
note = {Supported by the DFG in the framework of the DFG Clinician
Scientist Programme UMEA, FU356/12-2},
abstract = {AbstractBackgroundIntragastric botulinum neurotoxin
injections (IBNI) are offered off-label in the private
medical sector in a few European countries as a safe and
effective weight-loss measure. In February and March 2023,
an outbreak of iatrogenic botulism occurred in several
European countries following IBNI treatment in Turkey. This
case series describes the clinical features of severe
iatrogenic botulism after IBNI.MethodsWe retrospectively
summarize the clinical course and emergency department and
intensive care unit interventions in ten cases of severe
iatrogenic botulism that occurred after receiving IBNI in
this sudden outbreak in Austria and Germany.ResultsSeven out
of ten cases initially showed characteristic symptoms of
botulism with diplopia, dysphagia, dysarthria,
dysarthrophonia, and descending paralysis. All patients were
hospitalized, six in an intensive care unit and partially
requiring mechanical ventilation. All patients recovered and
were discharged without relevant permanent
deficits.ConclusionOur study highlights ten clinical cases
in this iatrogenic botulism outbreak, representing the
largest reported outbreak worldwide. Clinicians should be
aware of the risks associated with medical procedures
involving botulinum neurotoxins and ensure measures to
minimize the risk of iatrogenic botulism.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {5251 - Multilevel Brain Organization and Variability
(POF4-525)},
pid = {G:(DE-HGF)POF4-5251},
typ = {PUB:(DE-HGF)16},
pubmed = {39472968},
UT = {WOS:001344817300001},
doi = {10.1186/s42466-024-00350-3},
url = {https://juser.fz-juelich.de/record/1032442},
}